Metastatic Urothelial Cancer Recruiting Phase 2 Trials for Gemcitabine (DB00441)

Indication	Status	Phase
DBCOND0066157 (Metastatic Urothelial Cancer)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03547973	Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread	Treatment	Avelumab (DB11945) Carboplatin (DB00958) Cisplatin (DB00515) Gemcitabine (DB00441) Pembrolizumab (DB09037) Sacituzumab govitecan (DB12893) Zimberelimab (DB17505)